Sg Americas Securities, LLC Assembly Biosciences, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$15.08 - $27.04 $180,960 - $324,480	-12,000 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$14.57 - $23.96 $18,066 - $29,710	1,240 Added 11.52%	12,000 $280,000
Q1 2020 Apr 30, 2020	SELL	$10.27 - $21.23 $843,567 - $1.74 Million	-82,139 Reduced 88.42%	10,760 $160,000
Q4 2019 Jan 28, 2020	BUY	$8.36 - $23.81 $776,635 - $2.21 Million	92,899 New	92,899 $1.9 Million
Q3 2019 Nov 04, 2019	SELL	$9.83 - $14.82 $141,375 - $213,141	-14,382 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$12.9 - $20.8 $185,527 - $299,145	14,382 New	14,382 $194,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.